Objective: To assess the safety profile of acarbose treatment over a 1-year period at a dose range of 50 300mg three times daily in patients with type 1 or type 2 diabetes mellitus. Results ...
Objective and design: This post-marketing surveillance study collected data on the efficacy and tolerability of acarbose in patients with insulin-treated type 2 diabetes mellitus and, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback